Intravenous iron for the treatment of iron deficiency in ibd: The pendulum is swinging

American Journal of Gastroenterology

Volumn 108, Issue 12, 2013, Pages 1889-1890

  Van Assche, Gert ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC CARBOXYMALTOSE; FERRIC GLUCONATE; FERROUS SULFATE; FERUMOXYTOL; HEMOGLOBIN; IRON; IRON DEXTRAN; IRON ISOMALTOSE; IRON SACCHARATE; ISOMALTOSE; NULECIT; TRANSFERRIN; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANEMIA; COST EFFECTIVENESS ANALYSIS; DRUG DOSAGE FORM COMPARISON; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG TOLERANCE; ENTERITIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOCOMPROMISED PATIENT; INFUSION RELATED REACTION; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY; IRON THERAPY; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TRANSFERRIN BLOOD LEVEL; UNSPECIFIED SIDE EFFECT;

ANEMIA, IRON-DEFICIENCY; DISACCHARIDES; FEMALE; FERRIC COMPOUNDS; HUMANS; INFLAMMATORY BOWEL DISEASES; IRON; MALE;

EID: 84889690100     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.400     Document Type: Review

References (11)

1. Gasche C. Anemia in IBD: The overlooked villain. Inflamm Bowel Dis 2000; 6 : 142-50.
2. Gasche C, Berstad A, Befrits R et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007; 13 : 1545-53.
3. Katsanos K, Cavalier E, Ferrante M et al. Intravenous iron therapy restores functional iron deficiency induced by infliximab. J Crohns Colitis 2007; 1 : 97-105.
4. Schr ö der O, Mickisch O, Seidler U et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease - a randomized, controlled, open-label, multicenter study. Am J Gastroenterol 2005 ; 100 : 2503-9.
5. Krikorian S, Shafai G, Shamim K. Managing iron deficiency anemia of CKD with IV iron.us Pharm 2013; 8 : 22-6.
6. Reinisch W, Staun M, Tandon RK. A randomized, open label, non inferiority study of iron isomaltose 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PRO-CEED). Am J Gastroenterol 2013; 108 : 1877-88 (this issue).
7. Vavricka SR, Schoepfer AM, Safroneeva E et al. A shift from oral to intravenous iron supplementation therapy is observed over time in a large Swiss cohort of patients with inflammatory bowel disease. Inflamm Bowel Dis 2013; 19 : 840-6.
8. Ganzoni AM. Intravenous iron-dextran: Therapeutic and experimental possibilities . Schweiz Med Wochenschr 1970; 100 : 301-3.
9. Kulnigg S, Stoinov S, Simanenkov V et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: The ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 2008; 103 : 1182-92.
10. Evstatiev R, Marteau P, Iqbal T et al. FERGI Study Group. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology 2011 ; 141 : 846-53. e1-2.
11. Evstatiev R, Alexeeva O, Bokemeyer B et al. FERGI Study Group. Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2013; 11 : 269-77.